Clinical trial
Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle or Resection Cavity in Children With Recurrent Posterior Fossa Ependymoma: A Pilot Study
NCT02940483 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle or Resection Cavity in Children With Recurrent Posterior Fossa Ependymoma: A Pilot Study
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 1, 2017
- Completion date
- November 28, 2018
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain tumor recurrent